Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

TLX101 Demonstrated Efficacy in Recurrent High-Grade Glioma

April 16th 2025, 7:00pm

Article

TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from the phase 2 IPAX-Linz study.

Clinical Trial of NEO100 Recruiting Patients With Malignant Gliomas

April 15th 2025, 3:00pm

Article

A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment expected in September.

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

April 4th 2025, 3:12pm

Article

The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.

FDA Approves Initiation of a New Trial in Recurrent Glioblastoma

April 2nd 2025, 9:00pm

Article

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.

A New Comprehensive Hereditary Cancer Solution Has Been Launched

April 2nd 2025, 3:00pm

Article

A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.

Clinical Trial to Evaluate Opdivo, Opdualag in Glioblastoma

March 27th 2025, 8:53pm

Video

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

A VXM01 Vaccine Combination Generates Safe Responses in Glioblastoma

March 26th 2025, 9:00pm

Article

Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with recurrent glioblastoma.

Progress Reported in Phase 1 Trial of CLD-101 for Recurrent Glioma

March 26th 2025, 4:00pm

Article

A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral doses.

Pregnancy After Glioma Diagnosis Associated With Worse Progression Time

February 28th 2025, 4:00pm

Article

For female patients with glioma, pregnancy after receiving a diagnosis of glioma is associated with worse progression-free survival times.

Fractionated Reirradiation is Safe and Feasible in High-Grade Glioma

February 27th 2025, 10:00pm

Article

Fractionated reirradiation is safe and feasible, suggesting higher reirradiation dose may be feasible in patients with recurrent high-grade glioma.